Overview
GRCE market data
Price History
GRCE price chart · 1M
- O
- 2.11
- H
- 2.11
- L
- 2.09
- C
- 2.10
- Vol
- 5,570.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $2.11
- Previous Close
- $2.16
- Day High
- $2.11
- Day Low
- $2.09
- 52 Week High
- $5.15
- 52 Week Low
- $1.79
- 7 Day Return
- -1.41%
- 30 Day Return
- -1.87%
- 90 Day Return
- -9.09%
- 1 Year Return
- -53.13%
- Daily Notional Volume
- $11.7K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.35 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.39 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -4,435.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.79 – $5.18 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $44.2M · P/B 1.12 · P/S 220.88.
Company News
6 captured
8-K filing — Grace Therapeutics, Inc. (GRCE)SEC EDGAR ·